The "Shark Tank" star predicts three of the biggest psychedelic companies will merge into a mega corporation, but our resident Psychedelic Investor wonders: Should they?
Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder
Cybin announces a new clinical partner as it prepares for its Phase 1/2a clinical trial for CYB003.
Revitalist Reports Fourteen Months of Consecutive Monthly Visit Growth and a 466% Increase Year over Year for March 2022
Revitalist Lifestyle and Wellness announces 14th consecutive month of revenues growth and projects further growth across its network of 9 clinics.
Looking For The Perfect Inflation Hedge? Try This Company
Inflation is rapidly eroding our purchasing power and consuming our wealth. Here is a powerful antidote for investors.
Veterans Push to Persuade Lawmakers to Legalize Therapeutic Use of Psychedelics
New studies have indicated psilocybin could be useful in the treatment of everything from major depression to alcoholism.
Gold price attempts to take $2,000
Gold flirted with the $2,000 an ounce on Monday, led by safe-haven demand following a long weekend.
Magic mushrooms can lead to long-term improvements in depression, study finds
Magic mushroom's drug psilocybin can lead to long-term improvements in depression symptom severity, a small study has found.
Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other Psychedelic Compounds
Delic Holdings announces receiving a Health Canada 56 Research Exemption to conduct research on various psychedelic drugs.
Mydecine Announces Reverse Stock-Split
Mydecine Innovations Group announces a share consolidation of 1 post-consolidation share for every 50 pre-consolidation shares.
Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT
In many studies, DMT has shown to be a promising and effective psychedelic for the treatment of mental health issues.
Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway
Awakn Life Sciences reports that it now has three clinics in operation, including its new flagship clinic in London.
Red Light Holland Sponsors First Of Its Kind Group Microdosing Concert In The Netherlands
Red Light Holland to sponsor a "microdosing concert" in The Netherlands, given by mezza-soprano Helena van Heel.
